Home › Multiple sclerose › New York › New York City
Multiple sclerose klinische studies in New York City, NY
17 studies voor Multiple sclerose zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruterenFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of the MIND Diet for Persons With Multiple Sclerosis
Rekruteren
- Mount Sinai Hospital, New York
Vancomycin Study in Multiple Sclerosis (MS)
RekruterenFase 1
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RekruterenObservatieonderzoek
- TG Therapeutics Investigational Trial Site, New York
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RekruterenFase 1/2
- Mt. Sinai, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruterenFase 2
- NYU Langone Health, New York
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RekruterenFase 1
- TG Therapeutics Investigational Trial Site, New York
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
RekruterenFase 1
- Research Site, New York
- Research Site, New York
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RekruterenFase 1
- Columbia University Irving Medical Center, New York
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
RekruterenFase 2
- Mount Sinai School of Medicine, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
RekruterenFase 2
- NYU Langone Health, New York
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mount Sinai Hospital, New York
Genes and Environment in Multiple Sclerosis
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Columbia University Irving Center, New York
A Palliative Care Model Impact on Knowledge and Attitudes
Rekruteren
- Judith Jaffe Multiple Sclerosis Center, New York
- Hunter College, New York
NYSCF Scientific Discovery Biobank
RekruterenObservatieonderzoek
- New York Stem Cell Foundation Research Institute, New York
Eccentric Exercise and Fatigue in Multiple Sclerosis
RekruterenObservatieonderzoek
- Hunter College, Physical Therapy Department, City University of New York, New York
Effect of Cooling on Balance Performance in Multiple Sclerosis
RekruterenObservatieonderzoek
- Hunter College, Physical Therapy Department, City University of New York, New York
Multiple sclerose studies in andere steden
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- San Francisco, CA8 studies
- Birmingham, AL8 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Aurora, CO7 studies
- Columbus, OH7 studies
- Baltimore, MD7 studies
- Houston, TX6 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.